EATONTOWN, N.J. – January 13, 2014 – American CryoStem Corporation (OTCQB: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company will participate in the American Academy of Cosmetic Surgery (“AACS”) 30TH Annual Scientific Meeting to be held at the Westin Diplomat Resort & Spa near Fort Lauderdale, Florida, January 14-19, 2014.
The AACS 30th Annual Scientific Meeting is the premier gathering of cosmetic surgery professionals in the world. For six days, more than 1,000 practitioners, practice managers, exhibitors, researchers and allied health specialists will convene in Fort Lauderdale for unmatched educational and professional development opportunities. An array of symposia, general sessions, live patient demonstrations and keynote speakers will offer attendees a first-hand look at cutting edge procedural techniques, groundbreaking research and innovative technologies. This once-a-year occasion strengthens relationships and collaboration amongst a global network of cosmetic surgery professionals across many medical specialties.
EVENT AT A GLANCE
John Arnone – Chairman and CEO
John DiFolco – Director of Marketing
Dr. Mel Bircoll, M.D. – Member of Scientific and Medical Board
Dr. Richard Goldfarb, M.D., F.A.C.S – Member of Scientific and Medical Board
Dr. Frederic A. Stern, M.D., F.A.C.S. – Member of Scientific and Medical Board
Regenerative Stem Cell Therapies – Tuesday, January 14, 2014, 3:50-4:15 PM ET
Moderator: Dr. Stern
Topic: “Utilizing the American CryoStem ATGRAFT™ Service to Enhance Tissue Transfer Procedure Outcomes and Expand Tissue Transfer Services and Revenue.”
General Session – Thursday, January 16, 2014, 9:15-9:50 AM ET
Moderator: Dr. Bircoll
Topic: “The Myriad Cosmetic and Reconstructive Applications of Layered Autologous Fat Grafting”
Exhibit Hall Opens January 15-19, 2014 – Booth #232
The Westin Diplomat Resort & Spa
3555 South Ocean Drive
NOTE TO PRESS:
Qualified media are also invited to attend the event. Please contact Jackie Clark at 301-641-3750 or email@example.com or Fritz Schneider at 301-728-4811 or firstname.lastname@example.org for press credentials, either before or at the conference. To arrange one-on-one interviews with the Company, please contact Erin Palmer at Hanover|Elite at 407-585-1080 or via email at CRYO@hanoverelite.com.
About American CryoStem Corporation
A pioneer in the fields of Regenerative and Personalized Medicine, American CryoStem is a developer, marketer and global licensor of patented adipose tissue based cellular technologies and related proprietary services with a focus on clinical processing, commercial bio-banking and application development for adipose (fat) tissue and autologous adipose-derived regenerative cells (ADRCs). The Company maintains a strategic portfolio of intellectual property and patent applications that form its Adipose Tissue Processing Platform, which supports and promotes a growing pipeline of biologic products and processes, clinical services and international licensing opportunities. Through its ACS Laboratories division, the Company operates an FDA registered, cGMP compliant human tissue processing, cryo-storage and cell culture and differentiation media development facility in Mount Laurel, New Jersey. For more information, please visit www.americancryostem.com and www.acslaboratories.com.